Top

Published in:

30-08-2023 | Myocarditis | Review Article

Role of echocardiography in patients treated with immune checkpoints inhibitors

Authors: Kazuaki Tanabe, Junya Tanabe

Published in: Journal of Echocardiography | Issue 4/2023

Abstract

Immune-related adverse events occurring in the heart (cardiac immune-related adverse events; irAEs) by immune checkpoint inhibitors (ICIs) include myocarditis, arrhythmia, conduction disturbance, pericardial diseases, and takotsubo cardiomyopathy. Cardiac irAEs are rare but life-threatening. In cardio-oncology, the study of cardiac disorders caused by cancer treatment has recently attracted attention, and such studies may elucidate the pathophysiology of cardiac irAEs and contribute to management strategies. This review discusses the pathogenic mechanisms underlying cardiac irAEs and the role of echocardiography in patients treated with ICIs.

Onishi T, Fukuda Y, Miyazaki S, et al. Practical guidance for echocardiography for cancer therapeutics-related cardiac dysfunction. J Echocardiogr. 2021;19:1–20.CrossRefPubMed

Okura Y, Ozaki K, Tanaka H, et al. The impending epidemic of cardiovascular diseases in patients with cancer in Japan. Circ J. 2019;83:2191–202.CrossRefPubMed

Ball S, Ghosh RK, Wongsaengsak S, et al. Cardiovascular toxicities of immune checkpoint inhibitors. J Am Coll Cardiol. 2019;74:1714–27.CrossRefPubMed

Ramos-Casals M, Brahmer JR, Callahan MK, et al. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers. 2020;6:38.CrossRefPubMedPubMedCentral

Takahashi T, Tagami T, Yamazaki T, et al. Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192:303–10.CrossRefPubMedPubMedCentral

Kadowaki H, Akazawa H, Ishida J, Komuro I. Mechanisms and management of immune checkpoint inhibitor-related cardiac adverse events. JMA J. 2021;4:91–8.CrossRefPubMedPubMedCentral

Tajiri K, Aonuma K, Sekine I. Immune checkpoint inhibitor-related myocarditis. Jpn J Clin Oncol. 2018;48:7–12.CrossRefPubMed

Salem JE, Manouchehri A, Moey M, et al. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol. 2018;19:1579–89.CrossRefPubMedPubMedCentral

Ederhy S, Dolladille C, Thuny F, et al. Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication. Eur J Heart Fail. 2019;21:945–7.CrossRefPubMed

10.

Johnson DB, Balko JM, Compton ML, et al. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med. 2016;375:1749–55.CrossRefPubMedPubMedCentral

11.

Mahmood SS, Fradley MG, Cohen HV, et al. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol. 2018;71:1755–64.CrossRefPubMedPubMedCentral

12.

Wang DY, Salem JE, Cohen JV, et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol. 2018;4:1721–8.CrossRefPubMedPubMedCentral

13.

Escudier M, Cautela J, Malissen N, et al. Clinical features, management, and outcomes of immune checkpoint inhibitor-related cardiotoxicity. Circulation. 2017;136:2085–7.CrossRefPubMed

14.

Hu JR, Florido R, Lipson EJ, et al. Cardiovascular toxicities associated with immune checkpoint inhibitors. Cardiovasc Res. 2019;115:854–68.CrossRefPubMedPubMedCentral

15.

Palaskas N, Morgan J, Daigle T, et al. Targeted cancer therapies with pericardial effusions requiring pericardiocentesis focusing on immune checkpoint inhibitors. Am J Cardiol. 2019;123:1351–7.CrossRefPubMed

16.

Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229–361.CrossRefPubMed

17.

Rini B, Moslehi JJ, Bonaca M, et al. Prospective cardiovascular surveillance of immune checkpoint inhibitor-based combination therapy in patients with advanced renal cell cancer: data from the phase 3 JAVELIN Renal 101 trial. J Clin Oncol. 2022;40:1929–38.CrossRefPubMedPubMedCentral

18.

Awadalla M, Mahmood SS, Groarke JD, et al. Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis. J Am Coll Cardiol. 2020;75:467–78.CrossRefPubMedPubMedCentral

19.

Tanabe J, Watanabe N, Endo A, et al. Asymptomatic immune checkpoint inhibitor-associated myocarditis. Intern Med. 2021;60:569–73.CrossRefPubMed

20.

Tamura Y, Tamura Y, Takemura R, et al. Longitudinal strain and troponin I elevation in patients undergoing immune checkpoint inhibitor therapy. JACC CardioOncol. 2022;4:673–85.CrossRefPubMedPubMedCentral

21.

Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2018;36:1714–68.CrossRefPubMed

Title: Role of echocardiography in patients treated with immune checkpoints inhibitors
Authors: Kazuaki Tanabe
Junya Tanabe
Publication date: 30-08-2023
Publisher: Springer Nature Singapore
Keywords: Myocarditis
Electrocardiography
Electrocardiography
Pericardial Disease
Echocardiography
Echocardiography
Transthoracic Echocardiography
Published in: Journal of Echocardiography / Issue 4/2023
Print ISSN: 1349-0222
Electronic ISSN: 1880-344X
DOI: https://doi.org/10.1007/s12574-023-00621-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Role of echocardiography in patients treated with immune checkpoints inhibitors

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2023

Giant left ventricular lipoma

Abnormal inferior vena cava course mimicking inferior vena cava interruption with azygos continuation in the postoperative patient with omphalocele

Rapid progression of mitral stenosis during watchful waiting for the asymptomatic degenerative severe aortic stenosis: a case of caseous calcification of mitral annulus

Usefulness of post-systolic index in facilitating stratification of risk in patients with intermediate- or low-risk non-ST-segment elevation acute coronary syndrome

Controversies surrounding AI-based reporting systems in echocardiography

Esophageal varices seen in cardiac surgery